Skip to main content

3D LifePrints

ServiceLiverpool, United KingdomFounded 2013· One of 1986 Service companies tracked by AMPulse

Personalized surgery technology company providing FDA-cleared digital platform for surgical planning and patient-specific medical devices

CEO / Founder
Henry Pinchbeck
Team Size
11-50
Stage
Active
Total Funding
$4.54M
Latest Round
Series A
Key Investors
Nodenza Venture Partners (led $2.5M Series A), Fenwall Investments (led previous £500K Series A and £1.2M Growth rounds)

Technology & Products

Key Products

FDA-cleared EmbedMed digital platform for surgical planning, patient-specific surgical guides and models, orthopedic and CMF solutions, cleanroom manufacturing facilities

Technological Advantage

Hospital-embedded facilities, ISO certified, CMF surgery expertise, FDA clearance

Differentiation

Value Proposition

Embedded 3D printing hubs in hospitals for personalized surgery solutions

How They Differentiate

On-site hospital hubs, integrated surgical workflow, humanitarian origins

Market & Competition

Target Customers

NHS hospitals, Surgeons, Healthcare systems

Industry Verticals

Healthcare, Hospitals, Cranio-maxillofacial surgery, Orthopedics

Competitors

Materialise, Stratasys Medical, 3D Systems Healthcare

Growth & Milestones

Growth Metrics

{"planned_hubs": "London, Birmingham, Manchester, Leeds", "hospital_hubs": 3, "funding_raised": "£1.2M+", "expansion_markets": "UK, USA, Europe, Singapore"}

Major Milestones

US expansion with Texas facility; Former NASA astronaut added to leadership; £1.2M funding round 2020; £500K medical modeling expansion; Hubs at Alder Hey, Oxford, Wrightington; 2013: Founded in Kenya as Social Enterprise

Notable Customers

NHS hospitals, Alder Hey Childrens Hospital, Nuffield Orthopaedic Centre, Wrightington Hospital, Private hospitals, Research institutions, Universities, Medical device manufacturers, UN humanitarian sector

https://www.3dlifeprints.com

Why this company matters

Insight Surgery, formerly 3D LifePrints, operates a cross-Atlantic model that embeds additive manufacturing facilities directly within hospital systems. Its FDA-cleared EmbedMed platform digitizes the surgical planning workflow, enabling surgeons to order patient-specific guides, models, and devices produced on-site. This approach reduces lead times compared to centralized medical 3D printing services and integrates more closely with clinical workflows.

The company uses metal LPBF and polymer AM to manufacture surgical guides, anatomical models, and orthopedic and cranio-maxillofacial solutions. Its cleanroom facilities support ISO-certified production. Current hospital hubs include Alder Hey Children's Hospital in Liverpool, Nuffield Orthopaedic Centre in Oxford, and Wrightington Hospital, with expansion planned to London, Birmingham, Manchester, and Leeds. In the US, Insight Surgery has established a manufacturing presence at the Texas Medical Center.

Target customers include NHS hospitals, private healthcare systems, and research institutions. The company also supplies training aids to the United Nations humanitarian sector. Competitors include Materialise, Stratasys Medical, and 3D Systems Healthcare, but Insight Surgery differentiates through its on-site hub model and integrated digital platform, which covers the full workflow from imaging to device delivery.

Founded in 2013 as a social enterprise in Kenya, Insight Surgery has raised approximately $4.54M from investors including Nodenza Venture Partners and Fenwall Investments. Its leadership includes former NASA astronaut expertise. The key strategic question is whether the hospital-embedded hub model can scale beyond a handful of sites while maintaining FDA clearance and cost efficiency against centralized medical AM providers.